FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367603903> ?p ?o ?g. }

• W4367603903 endingPage "A018" @default.
• W4367603903 startingPage "A018" @default.
• W4367603903 abstract "Abstract The RAS family of GTPases (HRAS, KRAS, NRAS) continue to present formidable challenges to the design of compounds that successfully and specifically target oncogenic RAS mutant populations in cancer. Although recent advances have led to the successful development of inhibitors specific to KRAS G12C (such as Sotorasib [Amgen] and Adagrasib [Mirati Therapeutics]), ongoing efforts seek to develop additional targeted inhibitors for oncogenic mutants of KRAS. Development of new KRAS targeted inhibitors requires the understanding of how a mutation impacts the accessibility of key residues within the protein, along with how each candidate compound interacts with populations of mutant and wild-type proteins. Proteomic analyses, typically comprising peptide-based methods to confirm compound localization or quantify binding kinetics, represent a key validation step for each phase of the inhibitor development process. However, these methods may not always provide a clear picture of how effectively the compound binds to the protein, how specific the compound is to the target residue, and how concentration or incubation time may impact these factors. To address this, we have developed a novel assay to evaluate target engagement in vitro employing top-down proteomics, which entails the analysis of intact protein molecules and their modified forms (proteoforms). By analyzing intact labeled or compound-treated recombinant KRAS4B proteins, we can directly visualize and precisely characterize each species within a sample. This method allows us to easily detect nonspecific binding, identify targeting of incorrect residues, and characterize unanticipated compound reaction products within a short LC-MS run, all facilitated by targeted MS2 fragmentation. Moreover, we have developed complementary methods for RAS proteoform quantitation, allowing for the evaluation of compound engagement to all proteoforms with greater accuracy than traditional peptide-based methods. We first performed a proof-of-concept experiment using a panel of KRAS4B G12D_C118S proteins with selected residues modified to cysteine to evaluate reactivity to maleimide-biotin over time. We then applied our optimized top-down assay to determine the engagement of targeted covalent inhibitors Sotorasib and Adagrasib with KRAS WT, G12C, or G13C in both the active (GppNHp) and inactive (GDPβS) states. Finally, we selected three compounds from a large-scale screen against a UCSF Small Molecule Discovery Center compound library and evaluated each for specificity to KRAS4B G13C over KRAS4B WT and KRAS4B G12C. Our results show the concentration dependence of target engagement and directly map compound binding location(s) without disrupting the protein’s primary structure. Moreover, our ability to target discrete compound additions for top-down MS2 fragmentation provides context and order of preferential labeling of KRAS4B. Our hope is that this methodology may help accelerate the identification of new successful targeted inhibitors for KRAS and other RAS isoforms by the greater RAS community. Citation Format: Robert A. D'Ippolito, Caroline J. DeHart, Dana Rabara, Maria Abreu Blanco, Emily Alberico, Nitya Ramakrishnan, Stephanie Widmeyer, Simon Messing, David Turner, Michelle Arkin, Anna Maciag, Andrew Stephen, Dominic Esposito, Frank McCormick, Dwight V. Nissley. A top-down proteomic assay to evaluate KRAS4B-compound engagement [abstract]. In: Proceedings of the AACR Special Conference: Targeting RAS; 2023 Mar 5-8; Philadelphia, PA. Philadelphia (PA): AACR; Mol Cancer Res 2023;21(5_Suppl):Abstract nr A018." @default.
• W4367603903 created "2023-05-02" @default.
• W4367603903 creator A5000314948 @default.
• W4367603903 creator A5000465980 @default.
• W4367603903 creator A5009424096 @default.
• W4367603903 creator A5013510859 @default.
• W4367603903 creator A5030420068 @default.
• W4367603903 creator A5038311879 @default.
• W4367603903 creator A5043756020 @default.
• W4367603903 creator A5046377031 @default.
• W4367603903 creator A5061895849 @default.
• W4367603903 creator A5066372184 @default.
• W4367603903 creator A5069029588 @default.
• W4367603903 creator A5070024846 @default.
• W4367603903 creator A5070319506 @default.
• W4367603903 creator A5077235603 @default.
• W4367603903 creator A5082685256 @default.
• W4367603903 date "2023-05-01" @default.
• W4367603903 modified "2023-09-27" @default.
• W4367603903 title "Abstract A018: A top-down proteomic assay to evaluate KRAS4B-compound engagement" @default.
• W4367603903 doi "https://doi.org/10.1158/1557-3125.ras23-a018" @default.
• W4367603903 hasPublicationYear "2023" @default.
• W4367603903 type Work @default.
• W4367603903 citedByCount "0" @default.
• W4367603903 crossrefType "journal-article" @default.
• W4367603903 hasAuthorship W4367603903A5000314948 @default.
• W4367603903 hasAuthorship W4367603903A5000465980 @default.
• W4367603903 hasAuthorship W4367603903A5009424096 @default.
• W4367603903 hasAuthorship W4367603903A5013510859 @default.
• W4367603903 hasAuthorship W4367603903A5030420068 @default.
• W4367603903 hasAuthorship W4367603903A5038311879 @default.
• W4367603903 hasAuthorship W4367603903A5043756020 @default.
• W4367603903 hasAuthorship W4367603903A5046377031 @default.
• W4367603903 hasAuthorship W4367603903A5061895849 @default.
• W4367603903 hasAuthorship W4367603903A5066372184 @default.
• W4367603903 hasAuthorship W4367603903A5069029588 @default.
• W4367603903 hasAuthorship W4367603903A5070024846 @default.
• W4367603903 hasAuthorship W4367603903A5070319506 @default.
• W4367603903 hasAuthorship W4367603903A5077235603 @default.
• W4367603903 hasAuthorship W4367603903A5082685256 @default.
• W4367603903 hasConcept C104317684 @default.
• W4367603903 hasConcept C1167327 @default.
• W4367603903 hasConcept C143065580 @default.
• W4367603903 hasConcept C185592680 @default.
• W4367603903 hasConcept C207332259 @default.
• W4367603903 hasConcept C21790070 @default.
• W4367603903 hasConcept C2781187634 @default.
• W4367603903 hasConcept C46111723 @default.
• W4367603903 hasConcept C501734568 @default.
• W4367603903 hasConcept C502942594 @default.
• W4367603903 hasConcept C55493867 @default.
• W4367603903 hasConcept C70721500 @default.
• W4367603903 hasConcept C86803240 @default.
• W4367603903 hasConceptScore W4367603903C104317684 @default.
• W4367603903 hasConceptScore W4367603903C1167327 @default.
• W4367603903 hasConceptScore W4367603903C143065580 @default.
• W4367603903 hasConceptScore W4367603903C185592680 @default.
• W4367603903 hasConceptScore W4367603903C207332259 @default.
• W4367603903 hasConceptScore W4367603903C21790070 @default.
• W4367603903 hasConceptScore W4367603903C2781187634 @default.
• W4367603903 hasConceptScore W4367603903C46111723 @default.
• W4367603903 hasConceptScore W4367603903C501734568 @default.
• W4367603903 hasConceptScore W4367603903C502942594 @default.
• W4367603903 hasConceptScore W4367603903C55493867 @default.
• W4367603903 hasConceptScore W4367603903C70721500 @default.
• W4367603903 hasConceptScore W4367603903C86803240 @default.
• W4367603903 hasIssue "5_Supplement" @default.
• W4367603903 hasLocation W43676039031 @default.
• W4367603903 hasOpenAccess W4367603903 @default.
• W4367603903 hasPrimaryLocation W43676039031 @default.
• W4367603903 hasRelatedWork W2047609058 @default.
• W4367603903 hasRelatedWork W2155461614 @default.
• W4367603903 hasRelatedWork W2246525736 @default.
• W4367603903 hasRelatedWork W2268032170 @default.
• W4367603903 hasRelatedWork W2575300375 @default.
• W4367603903 hasRelatedWork W2790698431 @default.
• W4367603903 hasRelatedWork W3135289027 @default.
• W4367603903 hasRelatedWork W3168910478 @default.
• W4367603903 hasRelatedWork W3193746989 @default.
• W4367603903 hasRelatedWork W4284883430 @default.
• W4367603903 hasVolume "21" @default.
• W4367603903 isParatext "false" @default.
• W4367603903 isRetracted "false" @default.
• W4367603903 workType "article" @default.